Frontera Energy Corp (FEC)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 8.170 |
|---|---|
| 52-week range | 2.424 – 9.300 |
| Return, 1 month / 3 months | −2.2% / −10.7% |
| Return, 1 year / 3 years | +225.9% / +70.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 43 |
| Volatility (1 year) | 51.1% |
| Worst drawdown (1 year) | -12.3% |
| Average daily value traded | 0.43M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Frontera Energy Corp is an oil and natural gas company that explores for, develops and produces crude oil and gas, mainly in Colombia, with additional activities elsewhere in South America. Its operations include onshore fields producing heavy and light crude, along with exploration and appraisal work. The company supplies crude oil to energy markets and is headquartered in Calgary, Alberta, Canada, while its principal producing assets and operations are located in Colombia.
The shares are listed on the Toronto Exchange in Canada under the code FEC, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Frontera Energy Corp (FEC) trades on the Toronto Exchange in Canada. It last closed at CAD 8.170 on 23 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 197 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 225.9% and over the last three months it fell 10.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 82 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.9% | ||
| From 52-week high | -11.3% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -10.7% | ||
| 6-month return | 15.5% | ||
| 12-month return, skipping the last month | 233.1% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 51.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.3% | ||
| Liquidity | 42 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.43M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.2% |
|---|---|
| 1 month | −2.2% |
| 3 months | −10.7% |
| 6 months | +15.5% |
| 1 year | +225.9% |
| 3 years | +70.0% |
| 5 years | +104.6% |
Signals
| 50-day / 200-day average | 8.498 / 7.173 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.227 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Jun 2026 | CAD 8.3400 |
| 5 Jan 2026 | CAD 0.0625 |
| 2 Oct 2025 | CAD 0.0625 |
| 3 Jul 2025 | CAD 0.0625 |
| 2 Apr 2025 | CAD 0.0625 |
| 3 Jan 2025 | CAD 0.0625 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.